| Open | 50.9 |
| LTP | 43.23 |
| Previous Close | 49.9 |
| Day High | 52.09 |
| Day Low | 42.02 |
| Volume | 25440 |
| Code : | SAMYAKINT |
| Name : | SAMYAK INTERNATIONAL LTD. |
| Country : | India |
| Sector : | |
| Industry: |
| Market CAP : | 31 Cr |
| Stock P/E: | Not Available |
| ROCE: | 0% |
| Book Value: | 0 |
| Dividend Yield : | 0% |
| Most Recent Quarter : | 2024-06-30 |
| Revenue/Sales TTM : | 0 |
| Operating Margin TTM : | 0% |
| Return On Equity TTM : | 0% |
| Profit Margin : | 0% |
| Market Capitalization : | 31 Cr |
| EBITDA : | Not Available |
| Book Value : | 0 |
| PERatio : | Not Available |
| Dividend Share : | |
| Earnings Share : | 0 |
| Gross Profit TTM : | 6 Cr |
| Quarterly Earnings Growth YOY : | 0% |
| Dividend Yield : | % |
| Quarterly Revenue GrowthYOY : | 0 |
| Diluted Eps TTM : | 0 |
| Trailing PE : | 0 |
| Price Sales TTM : | 0.95 |
| Enter Prise Value : | 44 Cr |
| Enter Prise Value Ebidta : | 5.6552 |
| Forward PE : | 0 |
| Price Book MRQ : | 0.57 |
| Enter Prise Value Revenue : | 1.07 |
| Forward Annual Dividend Rate : | 0 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | |
| Last Split Date : | 0000-00-00 |
| Forward Annual Dividend Yield : | 0 |
| Dividend Date : | |
| Last Split Factor : |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 49.54 | 55.85 | 59.61 | 45.78 | 39.47 | 35.71 | 29.4 |
| Fibonacci | 52.1 | 57.13 | 62.17 | 47.06 | 42.03 | 36.99 | 31.96 |
| Camarilla | 48.27 | 55.21 | 58.34 | 45.14 | 38.2 | 35.07 | 28.13 |
| Classic | 55.94 | 59.05 | 66.01 | 48.98 | 45.87 | 38.91 | 35.8 |
| Days 50 Day MA |
15.99 |
| Days 200 Day MA |
10.48 |
| Days 52 Week High |
67.43 |
| Days 52 Week Low |
19.96 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Jun 2024 | 12 Cr | 11 Cr | 1 Cr | 0 | 15 Lac | 0 | 0 | 0 Cr | 0 |
| Mar 2024 | 24 Cr | 23 Cr | 1 Cr | 0 | 46 Lac | 1 Lac | 0 | 0 Cr | 0 |
| Dec 2023 | 7 Cr | 6 Cr | 1 Cr | 0 | 16 Lac | 0 | 0 | 0 Cr | 0 |
| Sep 2023 | 7 Cr | 5 Cr | 1 Cr | 0 | 12 Lac | 0 | 0 | 0 Cr | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2024 | 38 Cr | 33 Cr | 4 Cr | 0 | 74 Lac | 1 Lac | 0 | -1 Cr | 0 |
| Mar 2023 | 45 Cr | 43 Cr | 3 Cr | 0 | 61 Lac | 55 k | 67 Lac | -1 Cr | 0 |
| Mar 2022 | 46 Cr | 45 Cr | 60 Lac | 0 | 97 Lac | 3 Lac | 28 Lac | -1 Cr | 0 |
| Mar 2021 | 24 Cr | 28 Cr | -1 Cr | 0 | 98 Lac | -1 Lac | 4 Cr | 3 Cr | 0 |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 90 Cr | 29 Cr | 8 Cr | 23 Cr | 0 | 19 Cr | 68 Cr |
| Sep 2023 | 80 Cr | 24 Cr | 6 Cr | 10 Cr | 0 | 6 Cr | 70 Cr |
| Mar 2023 | 78 Cr | 20 Cr | 6 Cr | 11 Cr | 0 | 7 Cr | 67 Cr |
| Sep 2022 | 82 Cr | 16 Cr | 3 Cr | 11 Cr | 0 | 5 Cr | 70 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 90 Cr | 29 Cr | 8 Cr | 23 Cr | 0 | 19 Cr | 68 Cr |
| Mar 2023 | 78 Cr | 20 Cr | 6 Cr | 11 Cr | 0 | 7 Cr | 67 Cr |
| Mar 2022 | 84 Cr | 17 Cr | 4 Cr | 16 Cr | 0 | 7 Cr | 68 Cr |
| Mar 2021 | 98 Cr | 26 Cr | 11 Cr | 28 Cr | 0 | 16 Cr | 71 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Jun 2024 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2024 | 0 | 0 | 89 Lac | -6 Cr | 4 Cr | 4 Cr | 2 Cr |
| Mar 2023 | 0 | 0 | -1 Cr | 2 Cr | 3 Cr | 4 Cr | 2 Cr |
| Mar 2022 | 0 | 0 | 7 Cr | -2 Cr | 60 Lac | 3 Cr | 24 Lac |
| Mar 2021 | 0 | 0 | -5 Cr | -4 Lac | -1 Cr | 3 Cr | 17 Lac |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 19.80 | 19.85 | 19.90 | 20.00 |
20.05 |
20.15 | 20.20 | 20.25 |
| Date | Opening price | Closing price | Minimum price | Maximum price |
|---|---|---|---|---|
| 2024-12-31 | 42.75 | 41.85 | 40.11 | 42.75 |
| 2025-01-01 | 48 | 50.22 | 43.8 | 50.22 |
| 2025-01-02 | 50 | 47.9 | 45.4 | 55.9 |
| 2025-01-03 | 48.5 | 49.9 | 47 | 50.5 |
| 2025-01-06 | 50.9 | 43.23 | 42.02 | 52.09 |
| Open | 50.9 |
| LTP | 43.23 |
| Previous Close | 49.9 |
| Day High | 52.09 |
| Day Low | 42.02 |
| Volume | 25440 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company TITAN |
LTP 3470.4 |
Change 18.75 |
Gain 0.54 % |
|
Company BAJAJFINSV |
LTP 1684.6 |
Change 0 |
Gain 0 % |
|
Company WIPRO |
LTP 294.3 |
Change -0.15 |
Gain -0.05 % |
|
Company ICICIBANK |
LTP 1264.1 |
Change -0.95 |
Gain -0.08 % |
|
Company TCS |
LTP 4095 |
Change -4.9 |
Gain -0.12 % |
A seasonal rise in respiratory illnesses in China is drawing significant attention this year, especially on social media. The focus stems from unfounded comparisons to the Covid-19 pandemic, which began five years ago.A viral video claims to show a China hospital overrun with patients due to virus outbreaks.(X/@PhamDuyHien9)A viral video claims to show a China hospital overrun with patients due to...
China has witnessed an increase in the number of cases of human metapneumovirus (HMPV), a respiratory disease. Several social media posts have suggested that HMPV is rapidly spreading in the country, overwhelming its network of hospitals. The country is yet to declare HMPV as an epidemic but had last month revealed that they were setting up a protocol to handle unknown pathogens. The National Dis...
New Delhi: A top official of the country's repository of technical knowledge on medical issues has asked people not to panic over the spread of the Human Metapneumovirus (HMPV) in China. <!--[if !supportLineBreakNewLine]--> <!--[endif]-->Directorate General of Health Services (DGHS) official Dr Atul Goel suggested taking general precautions against all respiratory infections. &l...
A surge in infections caused by human metapneumovirus (HMPV) has been reported in China as the administration steps up screening, detection, and isolation protocols to deal with unknown pathogens.China has reported rising cases of HMPV, especially among those under 14 in northern provinces, Reuters reported, citing officials.The Chinese government is piloting a monitoring system for pneumonia of u...
Shares of Ola Electric Mobility came under fire on December 30, slipping over 3 percent after the slew of high-level exits in the company continued with the latest resignations of its Chief Marketing Officer and Chief Technology & Product Officer.Anshul Khandelwal, the company's Chief Marketing Officer, and Suvonil Chatterjee, Chief Technology & Product Officer, have stepped down from their roles,...
